ISOQOL 32nd Annual Conference
22-25 October 2025
Milwaukee, Wisconsin, USA
![AC_2025 Round](https://www.isoqol.org/wp-content/uploads/2024/07/AC_2025-Round.png)
Important Dates
Late November 2024:
Workshop and Symposium Abstract Submissions Open
28 March 2025:
Presenters notify their intent to present
(Workshops and Symposia)
Mid-May 2025:
Award Nominations Due
11 August 2025:
Presenter Registration Deadline
All Presenters Must Be Registered
15 October 2025:
Online Registration Closes
21 January 2025:
Workshop and Symposium Abstract Submissions Due
7 April 2025:
Oral, Brief & Poster Presentation Abstract Submissions Due
30 June 2025:
Presenters notify their intent to present
(Oral/Oral Brief/Poster)
22 September 2025:
Advanced Registration Deadline
Early March 2025:
Oral, Brief & Poster Presentation Abstract Submissions Open
16 May 2025:
Scholarship Applications Due
30 June 2025:
Early Bird Registration Deadline
29 September 2025:
ISOQOL Hotel Room Block Closes
Conference Theme
Artificial Intelligence & the Future of Quality of Life Research
Scientists worldwide are excited and concerned about the transformation of research with increasing use of artificial intelligence tools. Given ISOQOL’s vision to improve quality of life for people everywhere by creating a future in which their perspective is integral as well as our mission to advance the science of quality of life research, this year’s conference will focus on quality of life research in the context of artificial intelligence tools. Plenary sessions will focus on theory, methods, application, as well as cutting edge research.
Plenary Sessions
AI and the Future of Quality of Life Research
Our field exists to represent people’s experiences. This session will start with level-setting to establish a shared vocabulary for the conference, describing what AI is and how it differs from related concepts like machine learning. It will focus on the theoretical, philosophical, and ethical considerations of when and how artificial intelligences tools are used in quality of life and related patient-centered outcomes research. Benefits (e.g., mining unstructured conservations with AI for quality of life data) and pitfalls (e.g., privacy considerations, loss of patients’ voice) of the use of AI in quality of life research will be identified.
Cutting Edge Research
The Cutting Edge Research plenary session features some of the highest-ranked, innovative research from ISOQOL abstract submissions. In particular, these abstracts reflect research that truly “pushes the ISOQOL envelope” in providing new and different ways to look at quality of life.
Promising AI Tools for Quality of Life Researchers
The methods we use to develop and validate patient-reported outcome measures will evolve with the increasing use of artificial intelligence. This session will present the most promising AI tools for QOL researchers. For example, the use of natural language processing for analysis of qualitative data from concept elicitation interviews, use of generative AI for item development and translation, and use of advanced analytics in quantitative psychometrics or how to validate AI models using psychometric methods.
Use of AI in Quality of Life Research
Artificial intelligence is changing how patient-centered outcomes are captured and interpreted in clinical studies and in clinical practice. This session will explore varied use cases of AI for collecting and interpreting quality of life data from different perspectives such as researchers, regulators, and patients/caregivers. The application of AI for interpretation of meaningful change in quality of life will also be discussed.
Scientific Program Committee Co-Chairs
![Flynn, Kathryn_2024](https://www.isoqol.org/wp-content/uploads/2024/07/Flynn-Kathryn_2024.jpg)
Kathryn E. Flynn, PhD
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
![Tschosik, Betsy](https://www.isoqol.org/wp-content/uploads/2024/07/Tschosik-Betsy.jpg)
Elizabeth Tschosik, PhD
Genentech
Hinsdale, Illinois, United States
Thank You to Past Sponsors
![ardea_logo_tagline_colour](https://www.isoqol.org/wp-content/uploads/2023/07/ardea_logo_tagline_colour.png)
![Print](https://www.isoqol.org/wp-content/uploads/2023/03/AstraZeneca_Preferred-LOGO.jpg)
![logo_Bibliopro-negro-fondo-naranja](https://www.isoqol.org/wp-content/uploads/2024/08/logo_Bibliopro-negro-fondo-naranja.jpg)
![](https://www.isoqol.org/wp-content/uploads/2021/10/bms_logo_rgb_pos_300.png)
![Clarivate_Logo_TM_RGB_Color](https://www.isoqol.org/wp-content/uploads/2022/09/Clarivate_Logo_TM_RGB_Color.png)
![COS Logo](https://www.isoqol.org/wp-content/uploads/2023/04/COS-Logo.png)
![EORTC_Logo_FullName_without_Slogan_Pos (2)](https://www.isoqol.org/wp-content/uploads/2024/02/EORTC_Logo_FullName_without_Slogan_Pos-2.png)
![Evidera-PPD-Logo-FullColor 2022-01 (1)](https://www.isoqol.org/wp-content/uploads/2022/09/Evidera-PPD-Logo-FullColor-2022-01-1.jpg)
![FACIT_ComboLogo w tag_2023](https://www.isoqol.org/wp-content/uploads/2023/07/FACIT_ComboLogo-w-tag_300.jpg)
![FAM NET logo](https://www.isoqol.org/wp-content/uploads/2023/08/FAM-NET-logo.jpg)
![](https://www.isoqol.org/wp-content/uploads/2019/08/GENENTECH_REVISED_Logo2015.jpg)
![GSK_Signal_Full_Colour_RGB](https://www.isoqol.org/wp-content/uploads/2023/04/GSK_Signal_Full_Colour_RGB.png)
![](https://www.isoqol.org/wp-content/uploads/2019/08/HealthMeasureslogofoursystems.jpg)
![ICON logo high res](https://www.isoqol.org/wp-content/uploads/2024/06/ICON-logo-high-res-scaled.jpg)
![](https://www.isoqol.org/wp-content/uploads/2019/08/Incyte20Logo20420Color20PNG.jpg)
![IQVIA Technologies Logo Blue](https://www.isoqol.org/wp-content/uploads/2022/09/IQVIA-Technologies-Logo-Blue.png)
![Lumanity_Logo_Color (1)](https://www.isoqol.org/wp-content/uploads/2022/08/Lumanity_Logo_Color-1.png)
![](https://www.isoqol.org/wp-content/uploads/2019/08/MapiTrustlogo72DPI.jpg)
![](https://www.isoqol.org/wp-content/uploads/2021/10/Merck-logo_2021.jpg)
![](https://www.isoqol.org/wp-content/uploads/2021/04/OH_Logo_Main.png)
![](https://www.isoqol.org/wp-content/uploads/2019/08/OPTUM__RGB.jpg)
![Logo_OUI-Clinical-Outcomes](https://www.isoqol.org/wp-content/uploads/2022/11/Logo_OUI-Clinical-Outcomes.jpg)
![Logo](https://www.isoqol.org/wp-content/uploads/2022/08/PearsonLogo_Primary_Blk_RGB-scaled.jpg)
![](https://www.isoqol.org/wp-content/uploads/2021/09/Pfizer_Logo_Dark-Blue_RGB.jpg)
![QualityMetric RGB tagline](https://www.isoqol.org/wp-content/uploads/2022/09/QualityMetric-RGB-tagline.jpg)
![](https://www.isoqol.org/wp-content/uploads/2019/08/rochelogo.jpg)
![](https://www.isoqol.org/wp-content/uploads/2021/09/RWS_logo-rgb.png)
![Slice 1](https://www.isoqol.org/wp-content/uploads/2023/08/Slice-1-scaled.jpg)
![TP_Life Sciences_SS_RGB](https://www.isoqol.org/wp-content/uploads/2023/04/TP_Life-Sciences_SS_RGB.png)
![LO_GUeng_CMYK_flag](https://www.isoqol.org/wp-content/uploads/2023/08/LO_GUeng_CMYK_flag.png)
![](https://www.isoqol.org/wp-content/uploads/2021/06/VPG-logo-large-color-correct-2-Copyright-2021.png)
![Print](https://www.isoqol.org/wp-content/uploads/2022/09/YHEC-Logo_transparent-scaled.jpg)
![](https://www.isoqol.org/wp-content/uploads/2019/09/isoqol-logo-light.png)
The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).
Together, we are creating a future in which patient perspective is integral to health research, care and policy.